[33]
Radhika, S.; Gary, S.L.; Maktoob, A.; Alfred, J.W.; Gary, E.M.; Edward, L.E. Two-dimensional NMR studies of marine natural
products. IV. Isolation of the cembranoid diterpene jeunicin from
the mollusc planaxis sulcatus: Assignment of the proton and carbon
NMR spectra by two-dimensional techniques. Heterocycl. Chem., 1986, 23, 529-535.
[38]
Boehm, R. New pyrazole compounds. Part 2. Pharmazie, 1990, 45, 282-283.
[40]
Venkatesan, A.M.; Mansour, T. Preparation of bicyclic 6-
alkylidene-penems as β-lactamase inhibitors for use against bacterial
infections or diseases. WO Patent 2003093279A1, 2003.
[41]
Kato, T.; Katagiri, N. 3-(β-D-Ribofuranosyl)pyrazolo[3,4-
e][1,3]oxaziro-5,7-dione as a virucide.U.S. Patent 4656260,
[43]
Kolasa, T.; Patel, M.V. Sulfonylphenylpyrazoles as COX-2 inhibitors. WO2001016138, 2001.
[52]
Sweeney, M.J.; Davis, F.A.; Gutowski, G.E.; Hamill, R.L.; Hoffman, D.H.; Poore, G.A. Experimental antitumor activity of pyrazomycin. Cancer Res., 1973, 33, 2619-2623.
[54]
Lei, H.; Sheng, X.; Zhao, Z.; Hao, M.; Lu, J. Application of 3, 5- dinitrophenyl-pyrazolo[3,4-d][1,3]-oxazine as tumor drug resistance reversal agent. CN Patent 112402425A, 2020.
[57]
Borad, M.A.; Bhoi, M.N.; Rajani, D.P.; Rajani, S.D.; Patel, H.D. Synthesis and antimicrobial activities of 2-(4-substitutedphenyl)- 1,10B-dihydrospiro-[benzo[e]pyrazolo[1,5-c][1,3]oxazine-5,3′- indolin]-2′-one derivative from isatin. World J. Pharm. Pharm. Sci., 2014, 3, 805-821.
[61]
Wang, Y.; Zhao, L.; Shen, H.; Wang, D.; Zhang, X.; Ye, J.; Ge, C.; Liu, X.; Zhang, J.; Chen, H. Preparation of benzo[e]pyrazolo[1,5- c][1,3]oxazine compound and its application as anti-hepatitis. CN Patent 106008552A2, 2016.
[62]
Mccomas, C. C.; Liverton, N. J.; Habermann, J.; Koch, U.; Narjes, F.; Li, P.; Peng, X.; Soll, R.; Wu, H. Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases. WO Patent 2013033901A1, 2013.
[69]
Chappie, T.A.; Patel, N.C.; Verhoest, P.R.; Helal, C.J.; Sciabola, S.; Lachapelle, E.A.; Wager, T.T.; Hayward, M.M. 6,7-Dihydro- 5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds. WO Patent 2017145013A1, 2017.
[70]
Stafford, J.A.; Veal, J.M.; Trzoss, L.L.; McBride, C. Chemical compounds as inhibitors of interleukin-1 activity. WO Patent 2018136890A1, 2018.
[71]
Bryan, M.C.; Drobnick, J.; Gobbi, A.; Katsumoto, T.; Rajapaksa, N.; Kiefer, J.R. Benzofurans as IRAK4 modulators. WO Patent 2018234343A1, 2018.
[72]
Mc Bride, C.; Trzoss, L. L.; Boloor, A.; Sokolova, N.; Pastor, R. M.; Staben, S. T.; Stivala, C.; Volgraf, M.; Bronner, S. M. Sulfonimidamide compounds as inhibitors of interleukin-1 activity. WO Patent 2020018975A1, 2020.
[73]
Stafford, J. A.; Veal, J. M.; Trzoss, L. L.; Mc Bride, C.; Pastor, R. M.; Staben, S. T.; Stivala, C.; Volgraf, M. Sulfonylurea compounds as inhibitors of interleukin-1 activity. WO Patent 2020018970A1, 2020.
[74]
Wohlfahrt, G.; Toermaekangas, O.; Salo, H.; Hoeglung, L.; Karjalainen, A.; Knuuttila, P.; Holm, P.; Rasku, S.; Vesalainen, A. Androgen receptor modulating compounds. WO Patent 2011051540A1, 2011.
[75]
Riva, C.; Graziani, D.; Longhi, M.; Callegari, E.; Frigerio, F.; Angelico, P. Heterocyclylmethylidene derivatives and their use as modulators of mGluR5 receptors. WO Patent 2019002571A1, 2019.
[76]
Green, J.; Hopkins, M.; Jones, B.; Kiryanov, A. A.; Kuehler, J.; Monenschein, H.; Murphy, S.; Nixey, T.; Sun, H. Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamide as modulators of GPR6. WO Patent 2018183145A1, 2018.
[77]
Patel, S.; Hamilton, G.; Zhao, G.; Chen, H. Bicyclic amide compounds and methods of use thereof. WO Patent 2018100070A1, 2018.
[78]
Bonafoux, D.; Davis, H.M.; Frank, K.E.; Friedman, M.M.; Herold, J.M.; Hoemann, M.Z.; Huntley, R.; Osuma, A.; Sheppard, G.; Somal, G.K. Primary carboxamides as Btk inhibitors. WO Patent 2014210255A1, 2014.
[79]
Duncton, M.; O'Mahony, D. J. R.; Cox, M.; Estiarte-Martinez, M. L. A. Amides derivatives as ion-channel ligands, pharmaceutical compositions and methods of using the same. WO Patent 2009089057A1, 2009.
[80]
Roush, W.; Venkatraman, S.; Ghosh, S.; Shen, D.-M.; Katz, J.; Seidel, H.M. Compounds and compositions for treating conditions associated with NLRP activity. WO Patent 2020086732A1, 2020.